Details of the Drug
General Information of Drug (ID: DMPC4EK)
Drug Name |
EP-217609
|
|||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
Neutralizable NAPAP analog (thrombosis), Endotis; Neutralizable NAPAP analog (thrombosis), Organon; Fondaparinux analog + thrombin inhibitor (thrombosis), Endotis; Neutralizable Factor IIa/Factor X dual inhibitor (thrombosis), Endotis; Neutralizable Factor IIa/Factor X dual inhibitor (thrombosis), Organon
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Structure | ||||||||||||||||||||
3D MOL is unavailable | 2D MOL | |||||||||||||||||||
#Ro5 Violations (Lipinski): 5 | Molecular Weight (mw) | 2647.8 | ||||||||||||||||||
Topological Polar Surface Area (xlogp) | -7.5 | |||||||||||||||||||
Rotatable Bond Count (rotbonds) | 74 | |||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 18 | |||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 62 | |||||||||||||||||||
Chemical Identifiers |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
|||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | ||||||||||||||||||||||||||||||||
References